Navigation Links
More Fake Avastin Found in U.S., FDA Says
Date:4/4/2012

WEDNESDAY, April 4 (HealthDay News) -- The U.S. Food and Drug Administration says it has confirmed another counterfeit version of the cancer drug bevacizumab, most commonly known as Avastin, is being sold in the United States.

This time, the counterfeit product -- which the FDA says contains no active ingredient -- is posing as injectable Altuzan (bevacizumab) 400 mg/16ml, a Roche cancer medication that is approved for use in Turkey but not in the United States.

"Packaging or vials found in the U.S. that claim to be Roche's Altuzan with lot number B6021 should be considered counterfeit," the FDA said in a statement released Wednesday.

According to the FDA, medical practices got the fake Altuzan from "foreign sources" that include Richards Pharma (aka Richards Services), Warwick Healthcare Solutions or Ban Dune Marketing Inc (BDMI).

"Many, if not all of the products sold and distributed through this distributor have not been approved by the FDA," the agency said. The agency is urging all medical practices that believe they have received unapproved products from the three companies to "stop using [the products] and contact the FDA."

This is not the first time counterfeit Avastin has been spotted in the United States. In mid-February, Roche's Genetech unit warned of fake vials of Avastin. Later that month, the company said the fake drug was probably not harmful, but did not contain any active ingredient and so would be useless for people fighting cancer.

Doctors infuse Avastin to treat colon, lung, kidney and brain cancer.

According to the Associated Press, worldwide reports of drug counterfeiting have increased over the past 10 years.

More information

There's more on bevacizumab at the U.S. National Cancer Institute.

-- E.J. Mundell

SOURCES: U.S. Food and Drug Administration, news release, April 4, 2012; Associated Press


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Avastin Largely Safe for Patients With Type of Advanced Lung Cancer
2. FDA Advisers Say Avastin Shouldnt Be Used for Breast Cancer
3. FDA Advises Against Avastin as Treatment for Breast Cancer
4. More Evidence Links Avastin to Heart Failure in Breast Cancer Patients
5. More Evidence Cancer Drug Avastin May Cause Harm
6. NIH study finds Avastin and Lucentis are equally effective in treating AMD
7. Cancer Drug Avastin Makes Inroads Against Ovarian Tumors
8. FDA Panel Rejects Avastin for Breast Cancer
9. Avastin Rejection Supported by Cancer Experts
10. Clinical trial shows benefit to adding avastin to neoadjuvant chemotherapy in breast cancer patients
11. FDA Revokes Approval of Avastin for Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
More Fake  Avastin Found in U.S., FDA Says
(Date:1/18/2017)... West Lebanon, NH (PRWEB) , ... January 18, ... ... announces the launch of the revolutionary Active Brake Technology (ABT), an innovative braking ... and stability. , Active Brake Technology addresses one of the biggest concerns of ...
(Date:1/17/2017)... ... January 17, 2017 , ... Gym Source, America’s leading ... new showroom at South Dixie Hwy in Miami, FL. , “We are elated to ... “The new innovative in-store concept is designed to give clients a seamless and motivating ...
(Date:1/17/2017)... ... January 17, 2017 , ... SunView Software’s Service Smart Technology ... of the Year. , Each year, Pink Elephant recognizes a new product ... to address a specific business problem or opportunity. The award highlights original innovations that ...
(Date:1/17/2017)... ... ... Mirror Mirror Beauty Boutique, Houston’s premiere CoolSculpting provider , is proud ... Rewards Program. Practice founder, Paul Vitenas, MD FACS, is delighted that Mirror Mirror Beauty ... by Zeltiq, CoolSculpting is approved by the Food and Drug Administration as a safe ...
(Date:1/17/2017)... ... January 17, 2017 , ... SensorInsight ®, an Internet ... in the U.S.A. to offer Internet of Things (IoT) solutions based on ... sensor deployments such as monitoring solutions used to detect potentially hazardous conditions in ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... CAMBRIDGE, Mass. , Jan. 18, 2017  Tarix ... Drug Administration has granted a Rare Pediatric Disease (RPD) ... treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB), a rare ... for RDEB and treatment is limited to supportive care. ... supplements the Orphan Drug Designation previously granted by the ...
(Date:1/18/2017)... Jan. 18, 2017  Robust competition in the ... discounts on medicine prices, according to a new ... study is among the first to examine the share ... manufacturers, pharmacy benefit managers (PBMs), health plans and other ... study is the first to show what happens when ...
(Date:1/17/2017)... NEW YORK , Jan. 17, 2017 ... Summary GlobalData,s new report, "North America Insulin Delivery ... the North America Insulin Delivery market. The report provides ... and average prices (USD) within market segments - Insulin ... Accessories. The report also provides company shares and ...
Breaking Medicine Technology: